PALLIATIVE RADIATION THERAPY FOR BONE METASTASES

Course overview

BONE METASTASIS IS A COMMON OCCURRENCE IN MANY CANCERS, FREQUENTLY LEADING TO DEBILITATING SYMPTOMS SUCH AS PAIN, PATHOLOGIC FRACTURES, AND COMPROMISED QUALITY OF LIFE, WITH THE SPINE BEING THE MOST FREQUENT SITE OF TUMOR SEEDING. WITH ADVANCEMENTS IN SYSTEMIC THERAPIES PROLONGING THE LIFE EXPECTANCY OF CANCER PATIENTS, THE DEMAND FOR EFFECTIVE PAIN RELIEF AND FUNCTIONAL IMPROVEMENT THROUGH PALLIATIVE RADIATION THERAPY FOR BONE METASTASES HAS SIGNIFICANTLY INCREASED. THIS SURGE IN DEMAND HAS LED TO THE ESTABLISHMENT OF OUTPATIENT AND INPATIENT PALLIATIVE RADIOTHERAPY CENTERS, EMPHASIZING THE NEED FOR A COORDINATED, INTERDISCIPLINARY APPROACH TO OPTIMIZE PATIENT CARE. WITH AN ESTIMATED 280,000 NEW CASES OF BONE METASTASES ANNUALLY IN THE UNITED STATES, PRIMARILY ORIGINATING FROM CANCERS INCLUDING BREAST, PROSTATE, LUNG, BLADDER, THYROID, MELANOMA, KIDNEY, COLORECTAL, AND MULTIPLE MYELOMA, EFFECTIVE MANAGEMENT STRATEGIES ARE ESSENTIAL TO ALLEVIATE SYMPTOMS AND PREVENT FURTHER SKELETAL INJURY. UNDERSTANDING THE PURPOSE OF PALLIATIVE THERAPY, WHICH PRIORITIZES IMPROVING QUALITY OF LIFE OVER EXTENDING SURVIVAL, IS CRUCIAL FOR CLINICIANS INVOLVED IN CANCER CARE. THIS COURSE ENHANCES THE LEARNER'S UNDERSTANDING OF THE PURPOSE OF PALLIATIVE THERAPY, PATIENT SELECTION CRITERIA, TREATMENT MODALITIES, AND INDICATIONS, ENSURING THE MINIMIZATION OF ADVERSE EFFECTS AND THE ENHANCEMENT OF OVERALL QUALITY OF LIFE FOR CANCER PATIENTS WITH EXTENDED LIFE EXPECTANCY, AND UNDERSCORES THE IMPORTANCE OF AN INTERPROFESSIONAL TEAM IN DELIVERING HIGH-QUALITY CARE TO PATIENTS WITH BONE METASTASES.